|
Gênero PLC (GNS.L) Avaliação DCF
GB | Healthcare | Biotechnology | LSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Genus plc (GNS.L) Bundle
MASTER SEU GENUS PLC (GNSL) Análise de avaliação com nossa calculadora DCF de última geração! Equipado com dados reais (GNSL), este modelo do Excel permite ajustar as previsões e suposições para determinar com precisão o valor intrínseco do gênero PLC.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 551.4 | 574.3 | 593.4 | 689.7 | 668.8 | 703.4 | 739.7 | 778.0 | 818.2 | 860.5 |
| Revenue Growth, % | 0 | 4.15 | 3.33 | 16.23 | -3.03 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 |
| EBITDA | 68.0 | 82.3 | 79.8 | 87.5 | 73.7 | 89.8 | 94.4 | 99.3 | 104.4 | 109.8 |
| EBITDA, % | 12.33 | 14.33 | 13.45 | 12.69 | 11.02 | 12.76 | 12.76 | 12.76 | 12.76 | 12.76 |
| Depreciation | 36.9 | 35.1 | 39.1 | 43.7 | 46.9 | 46.1 | 48.4 | 50.9 | 53.6 | 56.3 |
| Depreciation, % | 6.69 | 6.11 | 6.59 | 6.34 | 7.01 | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
| EBIT | 31.1 | 47.2 | 40.7 | 43.8 | 26.8 | 43.7 | 46.0 | 48.4 | 50.9 | 53.5 |
| EBIT, % | 5.64 | 8.22 | 6.86 | 6.35 | 4.01 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 |
| Total Cash | 41.3 | 46.0 | 38.8 | 36.3 | 42.5 | 47.3 | 49.8 | 52.4 | 55.1 | 57.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 85.4 | 89.9 | 108.7 | 113.9 | 127.7 | 119.7 | 125.9 | 132.4 | 139.2 | 146.4 |
| Account Receivables, % | 15.49 | 15.65 | 18.32 | 16.51 | 19.09 | 17.01 | 17.01 | 17.01 | 17.01 | 17.01 |
| Inventories | 77.2 | 76.6 | 84.0 | 85.1 | 89.4 | 94.5 | 99.4 | 104.6 | 110.0 | 115.6 |
| Inventories, % | 14 | 13.34 | 14.16 | 12.34 | 13.37 | 13.44 | 13.44 | 13.44 | 13.44 | 13.44 |
| Accounts Payable | 18.5 | 23.7 | 36.0 | 34.8 | 34.0 | 33.3 | 35.0 | 36.8 | 38.7 | 40.7 |
| Accounts Payable, % | 3.36 | 4.13 | 6.07 | 5.05 | 5.08 | 4.74 | 4.74 | 4.74 | 4.74 | 4.74 |
| Capital Expenditure | -24.6 | -28.7 | -42.1 | -35.2 | -24.7 | -35.7 | -37.5 | -39.4 | -41.5 | -43.6 |
| Capital Expenditure, % | -4.46 | -5 | -7.09 | -5.1 | -3.69 | -5.07 | -5.07 | -5.07 | -5.07 | -5.07 |
| Tax Rate, % | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 | -43.64 |
| EBITAT | 23.7 | 40.0 | 34.4 | 37.0 | 38.5 | 37.6 | 39.5 | 41.6 | 43.7 | 46.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -108.1 | 47.7 | 17.5 | 38.0 | 41.8 | 50.2 | 41.1 | 43.3 | 45.5 | 47.8 |
| WACC, % | 6.28 | 6.41 | 6.41 | 6.41 | 6.64 | 6.43 | 6.43 | 6.43 | 6.43 | 6.43 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 189.8 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 50 | |||||||||
| Terminal Value | 2,049 | |||||||||
| Present Terminal Value | 1,501 | |||||||||
| Enterprise Value | 1,691 | |||||||||
| Net Debt | 249 | |||||||||
| Equity Value | 1,442 | |||||||||
| Diluted Shares Outstanding, MM | 66 | |||||||||
| Equity Value Per Share | 2,178.91 |
What You Will Receive
- Authentic GNSL Financial Data: Pre-loaded with Genus plc’s historical and projected figures for accurate analysis.
- Fully Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch the intrinsic value of Genus plc update in real-time as you make adjustments.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- User-Friendly Interface: Intuitive layout and straightforward instructions suitable for all experience levels.
Key Features
- 🔍 Real-Life GNSL Financials: Pre-filled historical and projected data for Genus plc.
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas calculate the intrinsic value of Genus using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Genus’s valuation immediately after implementing changes.
- Scenario Analysis: Evaluate and compare different financial outcomes side-by-side based on varying assumptions.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled data for Genus plc (GNSL) including historical and forecasted figures.
- Step 3: Modify the key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe the automatic updates reflecting Genus plc’s (GNSL) intrinsic value.
- Step 5: Utilize the results for your investment decisions or reporting needs.
Reasons to Use This Calculator for Genus plc (GNSL)
- Reliable Data: Utilize genuine Genus plc financials for trustworthy valuation outcomes.
- Flexible Options: Tailor essential metrics such as growth rates, WACC, and tax rates to fit your projections.
- Efficiency: Built-in calculations save you the trouble of starting from scratch.
- Professional Quality: Crafted for investors, analysts, and consultants in the field.
- Easy to Use: User-friendly design and guided instructions make it accessible for everyone.
Who Can Benefit from Genus plc (GNSL)?
- Professional Investors: Construct comprehensive and trustworthy valuation models for investment assessments.
- Corporate Finance Teams: Evaluate valuation scenarios to inform internal strategic decisions.
- Consultants and Advisors: Offer clients precise valuation insights regarding Genus plc (GNSL) stock.
- Students and Educators: Utilize real-world data to enhance financial modeling skills in academic settings.
- Animal Genetics Enthusiasts: Gain insights into the valuation methodologies applied to biotech firms like Genus plc (GNSL).
Contents of the Template
- Pre-Filled DCF Model: Genus plc’s financial data pre-loaded for immediate applicability.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Genus plc’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your scenarios.
- Financial Statements: Access annual and quarterly reports for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.